Hypertension and proteinuria as clinical biomarkers of response to bevacizumab in glioblastoma patients.

Bruno CarvalhoRafaela Gonçalves LopesPaulo LinharesAndreia CostaCláudia CaeiroAna Catarina FernandesNuno TavaresLígia OsórioRui Vaz

Published in: Journal of neuro-oncology (2020)

Our data suggest that hypertension and proteinuria can be effective predictors of response to antiangiogenic therapy in recurrent glioblastoma and are associated with longer disease control.

Keyphrases

blood pressure
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
machine learning
patient reported outcomes
mesenchymal stem cells
deep learning